Study on expression of SENP1 and c-myb gene in patients with acute lymphoblastic leukemia
10.3969/j.issn.1671-8348.2014.10.006
- VernacularTitle:急性淋巴细胞白血病患者SENP1和c-myb表达的研究
- Author:
Qingrong LI
;
Shuangnian XU
;
Jianmin ZHANG
;
Jieping CHEN
- Publication Type:Journal Article
- Keywords:
small ubiquitin-related modifier proteins;
ubiquitin-protein ligases;
genes,myb;
precursor cell lymphoblastic leukemi-a-lymphoma
- From:
Chongqing Medicine
2014;(10):1171-1174
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the SENP1 and c-myb gene expression and their correlations in bone marrow specimens in the patients with acute lymphoblastic leukemia (ALL ) to provide the basis for expounding the role ,mechanism and prognosis of SENP1 and c-myb in ALL .Methods 31 patients diagnosed with ALL (22 cases of B-ALL ,1 case of T-ALL and 8 cases of uncate-gorized ALL ;6 cases in the low/medium risk group ,25 cases in the high risk group) and 31 patients with proliferative bone marrow and hyperplastic anemia diagnosed by the morphology were taken as the control group .The real-time PCR and immunocytochemical staining(SP method) were adopted to detect the mRNA and protein expressions of SENP1 and c-myb in the bone marrow specimens of the ALL patients and the control group .Results The expression of SENP1 and c-myb were both increased in the bone marrow specimens and smears of ALL patients ,which showed the statistical difference compared with the control group (P< 0 .05) ,the Pearson correlation analysis found that the high expression of SENP1 and c-myb had correlation .The expression of SENP1and c-myb in the low/medium risk group were lower than that in the high risk group ,but the difference had no statistical significance . Conclusion The high expression of SENP1 and c-myb exists in the bone marrow specimens of the ALL patients ,SENP1 and c-myb could possibly have the correlation with the occurrence and development of ALL ;but now the differences of SENP1 and c-myb ex-pression among different risk groups of ALL patients are yet to be proven .
